Journal
KIDNEY RESEARCH AND CLINICAL PRACTICE
Volume 41, Issue 5, Pages 524-532Publisher
KOREAN SOC NEPHROLOGY
DOI: 10.23876/j.krcp.22.010
Keywords
Atypical hemolytic uremic syndrome; Classification; Complement C4d; Pathology; Thrombotic microangiopathies
Categories
Ask authors/readers for more resources
Thrombotic microangiopathy (TMA) is a condition caused by microvascular injury, characterized by thrombosis, hemolytic anemia, and thrombocytopenia. Atypical hemolytic uremic syndrome (aHUS) is a type of TMA that has diverse etiologies and clinical manifestations. Renal biopsy is an important diagnostic tool for TMA and can help identify TMA changes in other renal diseases.
Thrombotic microangiopathy (TMA) refers to a condition caused by microvascular injury that includes thrombosis, hemolytic anemia, and thrombocytopenia. There are two classic TMAs, hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura, as well as an atypical HUS (aHUS). aHUS includes a broad spectrum of disorders with diverse etiologies and shares clinical manifestations with classic TMA; however, it frequently lacks typical clinical and laboratory findings. These traits can confuse clinicians and pathologists in terms of renal pathologic diagnosis, especially in cases where TMA is associated with other glomerulopathies or hypertensive renal disease. In this review, new paradigms for classifying TMA and the diversity of histopathologic changes including associated renal diseases are discussed. Renal biopsy is an important and useful diagnostic tool for diagnosing TMA and identifying TMA changes in other renal diseases, including hypertension. Adopting the term TMA features for TMA-like changes in glomerulus or artery/ arteriole in addition to the pathological diagnosis of glomerulopathy would be informative to clinicians for a prompt diagnosis and treatment of aHUS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available